Korea Bio-Gen Co.Ltd (318000) — Cash Flow Reinvestment Rate
Korea Bio-Gen Co.Ltd (318000) has a Cash Flow Reinvestment Rate of 0.79x as of March 2026, reinvesting ₩115.48 Million (capex ₩42.14 Million plus investments ₩73.34 Million) from operating cash flow of ₩145.77 Million. Check 318000 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Korea Bio-Gen Co.Ltd Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for Korea Bio-Gen Co.Ltd across 9 annual periods. Explore Korea Bio-Gen Co.Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Korea Bio-Gen Co.Ltd (2017–2025)
Year-by-year capital reinvestment analysis for Korea Bio-Gen Co.Ltd. For live market cap and broader valuation context, see Korea Bio-Gen Co.Ltd (318000) total market value.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.11x | ₩8.12 Billion | ₩7.34 Billion | ₩462.42 Million | ▼ -33.5% |
| 2024 | 1.66x | ₩7.14 Billion | ₩4.29 Billion | ₩5.12 Billion | ▲ +86.3% |
| 2023 | 0.89x | ₩8.45 Billion | ₩9.47 Billion | ₩2.42 Billion | ▼ -63.9% |
| 2022 | 2.48x | ₩4.13 Billion | ₩1.67 Billion | ₩2.29 Billion | ▼ -26.7% |
| 2021 | 3.38x | ₩10.44 Billion | ₩3.09 Billion | ₩2.36 Billion | ▲ +563.3% |
| 2020 | 0.51x | ₩1.31 Billion | ₩2.58 Billion | ₩872.46 Million | ▼ -83.7% |
| 2019 | 3.12x | ₩9.53 Billion | ₩3.05 Billion | ₩2.55 Billion | ▲ +636.5% |
| 2018 | 0.42x | ₩840.93 Million | ₩1.98 Billion | ₩840.93 Million | ▼ -24.6% |
| 2017 | 0.56x | ₩777.66 Million | ₩1.38 Billion | ₩777.66 Million | — |